Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed

Abstract excerpt

Background: Immunotherapy has recently become a hot topic in the field of oncology, with PD-L1 playing a crucial role in this area. However, the research on PD-L1 correlation prediction models is not fully understood. The aim of our study was to investigate the role of PD-L1-related genes in lung adenocarcinoma immunity. Methods: The mRNA and clinical data were obtained from the Cancer Genome Atlas database....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Immunotherapy and Biomarkers
• Share to Ferroptosis and cancer prognosis
• Share to vaccines and immunoinformatics approaches